HeartSciences (HSCS) announced that the U.S. Food and Drug Administration has granted Breakthrough Device designationless than BDD, for its Aortic Stenosis ECG algorithm. The algorithm would offer a ...
Southlake, TX, June 04, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”) powered medical technology company ...
AccurKardia, an innovator in ECG-based diagnostics technology, has announced that its Aortic Valve Stenosis (AVS) ECG-based AI screening software has been granted Breakthrough Device Designation by ...
ECG Challenge: Tennis Player With an Irregular Pulse An active 45-year-old visits his physician for a routine exam and is found to have an irregular pulse. What does an ECG reveal in this otherwise ...
Southlake, TX, June 04, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (HSCS) (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial ...
HeartSciences Inc, an artificial intelligence-powered medical technology company focused on advancing the capabilities of ECGs/EKGs for the earlier detection of heart disease, announced that the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results